Generation of replication-competent and -defective HSV vectors

Area of Science:

• Gene therapy vector development
• Neuroscience
• Molecular biology

Background:

• Effective in vivo gene delivery vectors are essential for therapeutic gene products.
• Herpes simplex virus type 1 (HSV-1) is a promising vector for targeting the peripheral and central nervous systems.
• HSV-1 establishes lifelong latency in neurons with persistent episomal viral genomes.

Purpose of the Study:

• To describe the construction of replication-defective herpes simplex virus (HSV) vectors.
• To enable long-term transgene expression for gene therapy applications.
• To detail a method for generating high-purity HSV vectors.

Main Methods:

• Utilized a replication-deficient HSV vector backbone (TOZ.1) and homologous recombination with a shuttle plasmid.
• Inserted the gene of interest into the UL41 gene sequence, replacing a lacZ reporter gene.
• Employed a PacI endonuclease site to reduce nonrecombinant background and identified recombinants via clear plaques and PCR/Southern blot analysis.

Main Results:

• Successfully constructed replication-defective HSV vectors.
• Demonstrated the loss of reporter gene activity upon successful recombination.
• Confirmed recombinant vector structure using Southern blot or PCR analysis.

Conclusions:

• Developed a robust method for engineering replication-defective HSV vectors.
• These vectors are suitable for long-term transgene expression in vivo.
• The described technique facilitates the production of high-purity HSV vectors for gene therapy.